XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income $ 27,029 $ 37,753
Adjustments to reconcile net income to net cash provided by operating activities:    
Gain on disposition of property (120) (181)
Depreciation and amortization of deferred leasing costs 28,621 24,030
Amortization of deferred debt costs 1,252 1,145
Non-cash share-based compensation costs 908 724
Credit losses on operating lease receivables, net 606 515
(Increase) decrease in accounts receivable and accrued income (2,115) 2,189
Additions to deferred leasing costs (2,652) (4,174)
Decrease in other assets 5,231 3,323
Increase in accounts payable, accrued expenses, and other liabilities 3,527 2,967
Decrease in deferred income (5,309) (2,332)
Net cash provided by operating activities 56,978 65,959
Cash flows from investing activities:    
Acquisitions of real estate investments (31) 0
Additions to real estate investments (19,684) (10,889)
Additions to development and redevelopment projects (34,973) (79,486)
Proceeds from disposition of property 120 181
Net cash used in investing activities (54,568) (90,194)
Cash flows from financing activities:    
Proceeds from mortgage notes payable 0 100,000
Repayments on mortgage notes payable (17,590) (68,036)
Proceeds from revolving credit facility 55,000 51,000
Repayments on revolving credit facility (41,000) (91,000)
Proceeds from construction loans payable 34,437 64,302
Additions to deferred debt costs (125) (1,947)
Proceeds from the issuance of:    
Common stock 1,129 1,162
Partnership units 7,285 13,275
Distributions to:    
Common stockholders (28,550) (28,428)
Noncontrolling interests (12,395) (12,040)
Net cash provided by (used in) financing activities (7,406) 22,691
Net decrease in cash and cash equivalents (4,996) (1,544)
Cash and cash equivalents, beginning of period 10,299 8,407
Cash and cash equivalents, end of period 5,303 6,863
Supplemental disclosure of cash flow information:    
Cash paid for interest 32,456 23,972
Accrued capital expenditures included in accounts payable, accrued expenses, and other liabilities 16,463 43,494
Series D Cumulative Redeemable, 30,000 shares issued and outstanding    
Distributions to:    
Preferred stockholders (2,297) (2,297)
Series E Cumulative Redeemable, 44,000 shares issued and outstanding    
Distributions to:    
Preferred stockholders $ (3,300) $ (3,300)